HomeInsights52 Week Low Stocks

Aurobindo Pharma Ltd 52 Week Low

Aurobindo Pharma Ltd 52 Week Low

stocks purchased

₹ 0.8 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

6.2 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

YEARLOW

₹ 903.8

Last updated on: Nov 07, 2024

Key Highlights

  • The 52 Week Low of Aurobindo Pharma Ltd is ₹ 903.8 as of 07 Nov 24.

Company Fundamentals for Aurobindo Pharma Ltd

No data available

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241350.5
06 Nov 20241394.65
05 Nov 20241396.1
04 Nov 20241407.25
01 Nov 20241401.1
31 Oct 20241396
30 Oct 20241404.7
29 Oct 20241412.65
28 Oct 20241433.85
25 Oct 20241427.15

Asset Value vs Market Value of Aurobindo Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aurobindo Pharma Ltd

No data available

* All values are in crore

Aurobindo Pharma Ltd News Hub

News

Aurobindo Pharma to table results

Aurobindo Pharma will hold a meeting of the Board of Directors of the Company on 9 Novembe...

Read more

02 Nov 202412:52

News

Aurobindo Pharma completes acquisition of balance 49% stake in GLS Pharma

Aurobindo Pharma has completed the acquisition of balance 49% stake in its subsidiary, GLS...

Read more

25 Oct 202419:30

News

Aurobindo Pharma Ltd spurts 1.19%, up for fifth straight session

Aurobindo Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs...

Read more

09 Oct 202413:00

News

Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV

Aurogen South Africa, (Aurogen) a wholly owned step-down subsidiary of Aurobindo Pharma in...

Read more

05 Oct 202410:19

News

Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'

Aurogen South Africa (Aurogen), a wholly owned step-down subsidiary of Aurobindo Pharma in...

Read more

05 Oct 202410:21

News

Auro Pharma gets USFDA nod for urinary tract infections drug.

The approved drug is bioequivalent and therapeutically equivalent to the reference listed ...

Read more

03 Oct 202414:58

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Aurobindo Pharma Ltd

Why is it important to track the 52-week low of Aurobindo Pharma Ltd stocks?

Investors should monitor the 52-week low of Aurobindo Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Aurobindo Pharma Ltd stocks hitting a 52-week low?

Factors leading to Aurobindo Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Aurobindo Pharma Ltd stocks when they hit a 52-week low?

Buying Aurobindo Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Aurobindo Pharma Ltd stocks?

Investors should monitor the 52-week low of Aurobindo Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Aurobindo Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Aurobindo Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Aurobindo Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Aurobindo Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Aurobindo Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*